Recently, the well known industry chemist and blogger Derek Lowe, PhD discussed an important issue plaguing the drug development industry; a general lack of public knowledge with regard to how drugs are brought to market. Given the need for direct patient involvement in clinical trials, the issue is especially of great concern for our industry. The challenges and complexities of drug development are not easy tasks to relay to the layperson, but a greater attempt to bring public clarity to this process, would only benefit our shared goals: finding new therapies to treat disease...
